(Source: Drug and Alcohol Dependence)
BUPRENORPHINE HCL AND NALOXONE HCL (Buprenorphine And Naloxone) Tablet [A-S Medication Solutions LLC]
Updated Date: Jun 13, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
SUBOXONE (Buprenorphine Hydrochloride, Naloxone Hydrochloride) Film, Soluble [A-S Medication Solutions LLC]
Updated Date: Jun 13, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.
SUBOXONE (Buprenorphine Hydrochloride, Naloxone Hydrochloride) Film, Soluble [A-S Medication Solutions LLC]
Updated Date: Jun 13, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
BUPRENORPHINE HCL AND NALOXONE HCL (Buprenorphine And Naloxone) Tablet [A-S Medication Solutions LLC]
Updated Date: Jun 13, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE Tablet [Actavis Elizabeth LLC]
Updated Date: Jun 6, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE Tablet [Actavis Elizabeth LLC]
Updated Date: Jun 6, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.
Potentiation of the effect of buprenorphine/naloxone with gabapentin or quetiapine.
Authors: Reeves RR, Ladner ME
PMID: 24880512 [PubMed – in process] (Source: The American Journal of Psychiatry)
The Impact of Prior Authorization on Buprenorphine Dose, Relapse Rates, and Cost for Massachusetts Medicaid Beneficiaries with Opioid Dependence
ConclusionPrior authorization policies strategically targeted by dose level appear to successfully reduce use of higher than recommended buprenorphine doses. Savings from these policies are modest and may be accompanied by brief increases in relapse rates. Lower doses may decrease diversion of buprenorphine. (Source: Health Services Research)
Potentiation of the effect of buprenorphine/naloxone with gabapentin or quetiapine.
Authors: Reeves RR, Ladner ME
PMID: 24880512 [PubMed – in process] (Source: The American Journal of Psychiatry)